NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $2.19 -0.22 (-9.13%) Closing price 11/17/2026 04:00 PM EasternExtended Trading$2.19 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About P3 Health Partners Stock (NASDAQ:PIII) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get P3 Health Partners alerts:Sign Up Key Stats Today's Range$2.12▼$2.4150-Day Range$2.19▼$8.4352-Week Range$1.52▼$16.89Volume23,019 shsAverage Volume57,610 shsMarket Capitalization$15.90 millionP/E RatioN/ADividend YieldN/APrice Target$13.67Consensus RatingHold Company Overview P3 Health Partners is a physician-led healthcare company focused on helping independent physicians deliver coordinated, value-based care. Its model emphasizes preventive care and managing patients’ overall health, particularly for people enrolled in Medicare Advantage plans. The company supports participating providers with care coordination, data and technology, clinical resources, and administrative services. It also works with health plans under value-based arrangements, in which care is organized around patient outcomes and quality rather than solely the volume of services provided. Based in Henderson, Nevada, P3 has operated provider networks in states including Arizona, California, Nevada, Oregon, and Texas. The company became publicly traded in 2021 through a business combination with Foresight Acquisition Corp.AI Generated. May Contain Errors. Read More P3 Health Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScorePIII MarketRank™: 1.687783408905 of 5 starsP3 Health Partners scored higher than 34% of companies evaluated by MarketBeat, and ranked 685th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingP3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.Upside PotentialP3 Health Partners has a consensus price target of $13.67, representing about 524.0% upside from its current price of $2.19.Amount of Analyst CoverageP3 Health Partners has only been the subject of 2 research reports in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.21% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 0.84, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently increased by 21.02%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. News and Social Media1.2 / 5News Sentiment-0.15 News SentimentP3 Health Partners has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for P3 Health Partners this week, compared to 1 article on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders10.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PIII Stock News HeadlinesP3 Health Partners (NASDAQ:PIII) Stock Gets Price Target Reduction from TD CowenNovember 14, 2026 | americanbankingnews.comNasdaq Listing at Risk as P3 Health Partners’ Equity Classification Threatens Compliance With Rule 5550(b)(1)November 11, 2026 | tipranks.comPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.November 18 at 1:00 AM | OilPrice (Ad)P3 Health Partners Inc. (PIII) Q3 2026 Earnings Call TranscriptNovember 9, 2026 | seekingalpha.comP3 Health Partners Announces Third Quarter 2026 ResultsNovember 9, 2026 | businesswire.comP3 Health Partners (PIII) Set to Release Earnings on MondayNovember 8, 2026 | americanbankingnews.comP3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference CallOctober 22, 2026 | businesswire.comP3 Health Partners forecasts $80M-$110M in 2026 adjusted EBITDA following Q2 settlementsAugust 10, 2026 | seekingalpha.comSee More Headlines PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $3.49 at the beginning of the year. Since then, PIII shares have decreased by 37.2% and is now trading at $2.19. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) announced its earnings results on Monday, November, 9th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($3.96) by $4.03. The firm earned $396.34 million during the quarter, compared to analyst estimates of $384.95 million. Read the conference call transcript. When did P3 Health Partners' stock split? P3 Health Partners's stock reverse split before market open on Monday, April 14th 2025.The 1-50 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 11th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. Who are P3 Health Partners' major shareholders? P3 Health Partners' top institutional investors include Diversified Trust Co (0.32%). Insiders that own company stock include Pacific Founders Ugp I Chicago and Hudson Vegas Investment Spv, L. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of P3 Health Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include NVIDIA (NVDA), BigBear.ai (BBAI), Lyra Therapeutics (LYRA), Applied Digital (APLD), Arqit Quantum (ARQQ), Cybin (HELP) and Intel (INTC). Company Calendar Last Earnings11/09/2026Today11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 8 days, PIII's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:PIII CIK1832511 Webwww.p3hp.org Phone(312) 822-8897FaxN/AEmployees320Year FoundedN/APrice Target and Rating Average Price Target for P3 Health Partners$13.67 High Price Target$23.00 Low Price Target$4.00 Potential Upside/Downside+524.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($23.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$147.95 million Net Margins-3.30% Pretax Margin-8.17% Return on EquityN/A Return on Assets-9.38% Debt Debt-to-Equity RatioN/A Current Ratio0.53 Quick Ratio0.53 Sales & Book Value Annual Sales$1.46 billion Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book Value($10.30) per share Price / Book-0.21Miscellaneous Outstanding Shares7,260,000Free Float6,472,000Market Cap$15.90 million OptionableNot Optionable Beta1.81 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:PIII) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.